Background
Introduction
In South Africa, it is estimated that there are just under 6 million people living with HIV/AIDS. 1 In the last five years, the South African government has established the largest antiretroviral therapy (ART) program in the world 2 with almost a million adults on treatment by the end of 2009. 3 The official plan of the South African government is to provide an appropriate package of care to 80% of people living with HIV and their families by the end of 2011. 4 This requires a comprehensive service underpinned by early HIV diagnosis, with enrolment and retention in care and access to ART for those who qualify as soon as possible.
However, meeting these targets presents significant challenges, chief amongst which is the continued loss to follow up from pre-ART care 5, 6, 7 and poor retention in care prior to ART initiation. 8, 9, 10 This often results in patients presenting late to clinical services with low CD4 counts and subsequent high mortality rates within the first year. 11 Distance from health centre, a history of TB treatment, male gender, referral by third parties, psychosocial factors such as stigma, denial of HIV status, and undocumented mortality have all been identified as factors that explain loss to care after diagnosis or during treatment. [5] [6] [7] [8] [9] [10] Furthermore, analyses of the steps patients have to go through in order to eventually receive treatment have shown attrition at every stage. 5, 6 In one study, out of 7005 newly diagnosed HIV positive patients, only 43 . 5% presented for CD4 testing; despite half being eligible for ART, only a third (31 . 3%) started ART.
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In South Africa, CD4 testing is done through centralized laboratories with results usually available to the patient within one week. Currently, in inner city Johannesburg, newly diagnosed HIV infected patients are asked to return to the HIV counseling and testing site one week after their HIV test to collect their CD4 result. At this visit the patients' eligibility for treatment is assessed and where appropriate, referrals are made to local treatment centers to implement treatment. On average, 1300 people are seen every month for HIV testing at the site of this study, with 30% testing positive. Only
55-65% of patients tested, return to collect their CD4 results. 12 Various strategies have been employed to minimize the impact of such loss including active patient follow up with telephone calls and/or written instructions, with varying degrees of success. 6, 8, 13 Policy makers have proposed reducing the number of steps in the process as well as reducing the time lag between diagnosis and treatment. The provision of a CD4 result immediately after HIV diagnosis 6, 7, 14 could meet those requirements and would allow for patients to be tested, receive their CD4 on the same day if HIV infected with subsequent enrolment in appropriate care.
This study evaluated the impact of providing a CD4 count result at HIV diagnosis or written information on enrolment into pre-ART or ART care in a large urban primary health care clinic in Johannesburg.
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Methods
A randomized three-arm study was conducted at an urban primary healthcare clinic (Esselen clinic) in the inner city of Johannesburg from August to December 2009.
Services available at the clinic include HIV counseling and testing, antenatal services, TB treatment and monitoring, pre-ART care, child health surveillance, STI and family planning. The clinic serves a catchment area that is densely populated and industrialized.
Unemployment, alcohol abuse, sex work, poverty and gender violence are common, with a significant proportion of the community not from South Africa.
The inclusion criteria were adults over the age of 18 who had already received pre-test counseling and were awaiting HIV testing. Patients were excluded if they were pregnant as their options for further care was based on higher CD4 count cut-offs. Patients who had WHO stage IV clinical disease at presentation were also excluded as they were required to start empirical ART regardless of CD4 count.
The model of care in operation for study subjects started with pre-test counseling, followed by HIV testing using rapid antibody based tests; Advanced Quality One Step informed of the study arm to which they had been assigned by the counselor after posttest counseling and patient interviews had been completed which allowed sufficient time for on-site CD4 counts to be ready. Receipt of an immediate CD4 result after diagnosis permitted further care staging by a professional nurse on the same day. Those patients randomized to the leaflet arm were given printed material in a Z-fold 6 page leaflet designed by facility-based clinicians and described the HIV care pathway available to patients in the area. The leaflet was given to participants by counselors after randomization occurred with a brief explanation of its use. Participants in the leaflet and standard arms were asked to return to the clinic in 7 days to collect their CD4 result and further care staging thereafter.
The further care protocol in operation at the clinic was based on a CD4 count. Although 
Outcome measures and Statistical Analysis
The proportion of enrolled patients reporting for further care was compared by intervention arm based on arrival at pre-ART care site within one month of HIV testing if CD4 >215 cells/ µL or arrival at ART initiation site within three months if CD4 <=215 cells/ µL. X 2 test for measures of association and risk ratio analyses were used to compare these outcomes.
For secondary endpoints, outcomes of interest included the effect of intervention arm on time taken from HIV testing to various end points in the patient care pathway. Wilcoxon rank sum analysis was used for intervention arm comparisons. Identification of independent predictors for continued engagement in care was also assessed using p=0 . 0004). Table 1 Secondary Endpoints:
Time taken to report to pre-ART site
The median time to report to pre-ART care from time of HIV diagnosis was lower in the immediate arm and leaflet arms -7 days(IQR 1-18d ; IQR 7-9d respectively), whereas in the NC arm, median time to arrival at pre-ART site was 13 days (IQR 7-23d). Figure 1 Wilcoxon rank sum analyses were significant; immediate vs NC (z=1.972; p<0.04) and leaflet vs NC (z=1.935; p<0.05)
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Univariate and Multivariate analysis
Univariate analysis showed that age, employment, nationality and source of referral could potentially be associated with likelihood of reporting to further care (Table 2a) . After multivariate logistic regression, with reference age category 25-29yrs; age 19-<25yrs was associated with reduced engagement in further care. As age increased, so did an increased likelihood of enrollment in further care (Table 2b ).
This association was confirmed by trend tests.
Losses to enrollment in further care
Observed losses were 50/81(62%) in the immediate arm, 48/72(67%) in the leaflet arm and 40/67(60%) in the NC arm for patients requiring pre-ART care.
In ART eligible patients, losses experienced were 15/43(35%); 22/35(63%) and 27/36(75%) in the immediate, leaflet and NC arms respectively. Figure 2 In the standard collection arms (NC and leaflet), 112/220 (51%) returned to collect their CD4. Comparison of this group of returnees with patients in the immediate arm showed that the returning patients were 1.98x more likely to present for pre-ART care (RR=1 . 98, 95%CI=1 . 42-2 . 75, p=0 . 0002).
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Discussion
Pre-treatment loss to care continues to be a source of concern for health planners in South Africa. However, the reasons for this are complex and resolving the issue of linkage to care remains difficult. In this study, we have shown that decentralizing one aspect of the HIV care pathway by removing the need to send CD4 venous samples away for analysis has resulted in a partial reduction in loss to care. In patients who are eligible for ART, the High pre-ART losses persist with almost 1 in 2 patients in this study failing to collect their laboratory CD4 result one week after HIV diagnosis. To mitigate this loss, the introduction of rapid CD4 testing with a short turnaround time for results has been proposed. 6 However, even with the knowledge of a CD4 at time of HIV testing, only 40%
enrolled for monitoring at the pre-ART/wellness clinic and 65% of those eligible for ART presented for treatment. Similar findings have been observed in other studies too. In another Johannesburg based study, 59% of those with CD4 counts between 251 and 350 cells/µL had not returned to care within 1 year 20 and in Zambia, only 11% of the non-ART patients returned.
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possible determinants for pre-treatment loss to care in patients eligible for ART. Such factors include death, fear of stigma, socioeconomic issues including. financial, lack of transport, difficulty with being away from their place of employment, quality of providerpatient relationships, a history of TB treatment or male gender. 5,7_10 However, it cannot be assumed that similar factors apply for retention in care in the non-ART patient without further investigation. Patients with relatively high CD4 counts are on the whole well and may not see engaging in care as a priority as has been proposed in other studies 22 . Contributing to this, is the paucity of effective models for pre-ART care which inform how this aspect of care can be delivered probably because resources have been directed at improving ART rollout at the expense of pre-ART care. Equally, health care professionals and as a consequence patients, may also perceive pre-ART care as less important than ART care. This has significant implications as South Africa has embarked on improving HIV counseling and testing rates and at the current CD4 count cut off for treatment, we are bound to observe an increase in patients needing pre-ART care;
reaching this group of patients will need to be prioritized.
This study has some limitations. Firstly, we cannot be certain that patients lost to our follow up did not access care elsewhere, as newly diagnosed patients are not assigned unique identifiers and are therefore not traceable within the health care system. Moreover, with the possible overestimation of loss to care as proposed in other studies 23 , the outcomes of this study could be affected. In addition, without continued follow up of our cohort, we are unable to show that our observations persist beyond initial presentation at the further care site particularly as attrition rates post ART initiation have been well documented. 5, 7, 8 Finally, this study did not explore the cost effectiveness of immediate 
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CD4 count provision after HIV diagnosis, as the focus was on assessing the impact of the intervention on patient care. Effective decentralization of CD4 diagnostics would need to be informed by cost-benefit analyses when evaluated against current CD4 count delivery models.
In summary, we found that loss to ART initiation was decreased through making a CD4 result immediately available after HIV diagnosis but the use of an information leaflet did not have an impact on retention rates. In addition, retaining younger HIV infected individuals continues to be a concern suggesting that our current models of care remain suboptimal and need review. Basing HIV care after diagnosis around CD4 cut-offs necessitates that HIV infected patients will be assigned to either of the two models of 
